Delivery Order SPE2DB20D1100-SPE2DB25FD0X8

Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.38 firm fixed-price contract is for the delivery of Topiramate 25 mg tablets in quantities of 500s. The contract has an ultimate completion date of May 29, 2025 and is not set aside for any special designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of topiramate 25 mg tablets. The $2,439.05 firm-fixed price delivery order contract has a completion date of June 6, 2025 and is not a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,331.39 firm fixed price contract is for the delivery of 500 tablets of the medication topiramate 25 mg. The award has a completion date of June 5, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,302.49, is for the delivery of 500 tablets of the medication topiramate 25 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a $22,218.31 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4561313560 topiramate ER 100mg capsules. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for the company to provide a...
This federal contract award is for the delivery of 1,000 units of 50 mg topiramate tablets. The award was made by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The total ceiling value of the contract is $1,299.99, with a firm fixed price pricing type. The contract is a delivery order with a completion date of December 17, 2024. It is not designated as a set-aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,227.35 firm fixed-price contract is for the delivery of 500 tablets of 25 mg Topiramate, a medication used to treat various neurological conditions. The contract has an ultimate completion date of June 10, 2025 and is not a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,120.92 firm fixed-price delivery order is for the supply of 30 capsules of the drug Topiramate ER 50 mg. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Topiramate 25 mg tablets, a pharmaceutical product, with a ceiling value of $13,609.76 and a period of performance through March 7, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,392.10, is for the delivery of 4,567,237 units of 25 mg Topiramate tablets to support military healthcare programs. The contract is a firm fixed-price delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD0X8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,055.46, is for the delivery of 25 mg topiramate tablets. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/24/25, 11:09 AM